JMI Syringes & Medical Devices Limited (DSE:JMISMDL)
Bangladesh · Delayed Price · Currency is BDT 156.10
+4.80 (3.17%)
At close: Jul 6, 2026
DSE:JMISMDL Income Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 1,674 | 1,884 | 1,794 | 1,755 | 2,438 | 1,994 | |
Revenue Growth (YoY) | -12.91% | 5.02% | 2.19% | -28.01% | 22.31% | 0.86% |
Cost of Revenue | 1,489 | 1,591 | 1,504 | 1,534 | 2,049 | 1,657 |
Gross Profit | 184.77 | 293.19 | 289.79 | 221.49 | 389.31 | 336.76 |
Selling, General & Admin | 157.49 | 156.82 | 155.77 | 141.69 | 176.37 | 150.89 |
Other Operating Expenses | 0.05 | 0.42 | 0.11 | 7.96 | - | - |
Operating Expenses | 158.14 | 157.84 | 156.49 | 150.24 | 176.97 | 151.29 |
Operating Income | 26.62 | 135.35 | 133.3 | 71.24 | 212.34 | 185.46 |
Interest Expense | -0.11 | -0.43 | -2.52 | -12.93 | -13.18 | -11.18 |
Interest & Investment Income | 1.54 | 1.45 | 0.27 | 1.42 | 6.89 | 10.4 |
Currency Exchange Gain (Loss) | -1.82 | -7.09 | -5.31 | - | -0.18 | 0.77 |
Other Non Operating Income (Expenses) | -76.62 | -0.17 | 5.33 | 4.73 | 1.79 | 0.71 |
EBT Excluding Unusual Items | -50.39 | 129.11 | 131.07 | 64.46 | 207.67 | 186.17 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.05 | - |
Pretax Income | -50.39 | 129.11 | 131.07 | 64.46 | 207.72 | 186.17 |
Income Tax Expense | 42.26 | 84.18 | 92.19 | 214.43 | 107.12 | 97.06 |
Net Income | -92.65 | 44.92 | 38.88 | -149.96 | 100.6 | 89.11 |
Net Income to Common | -92.65 | 44.92 | 38.88 | -149.96 | 100.6 | 89.11 |
Net Income Growth | - | 15.54% | - | - | 12.89% | -7.22% |
Shares Outstanding (Basic) | 30 | 30 | 30 | 30 | 30 | 30 |
Shares Outstanding (Diluted) | 30 | 30 | 30 | 30 | 30 | 30 |
EPS (Basic) | -3.08 | 1.49 | 1.29 | -4.99 | 3.35 | 2.96 |
EPS (Diluted) | -3.08 | 1.49 | 1.29 | -4.99 | 3.35 | 2.96 |
EPS Growth | - | 15.54% | - | - | 12.89% | -7.22% |
Free Cash Flow | 78.46 | 99.2 | 109.46 | 21.29 | -57.08 | 124.8 |
Free Cash Flow Per Share | 2.61 | 3.30 | 3.64 | 0.71 | -1.90 | 4.15 |
Dividend Per Share | 1.000 | 1.000 | 1.000 | 1.000 | 3.600 | 2.206 |
Dividend Growth | - | - | - | -72.22% | 63.20% | - |
Gross Margin | 11.04% | 15.56% | 16.16% | 12.62% | 15.97% | 16.89% |
Operating Margin | 1.59% | 7.18% | 7.43% | 4.06% | 8.71% | 9.30% |
Profit Margin | -5.53% | 2.38% | 2.17% | -8.54% | 4.13% | 4.47% |
Free Cash Flow Margin | 4.69% | 5.27% | 6.10% | 1.21% | -2.34% | 6.26% |
EBITDA | 91.68 | 201.6 | 204.06 | 145.51 | 285.59 | 256.73 |
EBITDA Margin | 5.48% | 10.70% | 11.38% | 8.29% | 11.71% | 12.88% |
D&A For EBITDA | 65.05 | 66.25 | 70.75 | 74.27 | 73.24 | 71.27 |
EBIT | 26.62 | 135.35 | 133.3 | 71.24 | 212.34 | 185.46 |
EBIT Margin | 1.59% | 7.18% | 7.43% | 4.06% | 8.71% | 9.30% |
Effective Tax Rate | - | 65.21% | 70.34% | 332.63% | 51.57% | 52.14% |
Advertising Expenses | - | 9.54 | 8.98 | 9.1 | 12.47 | 6.04 |